James A. Posey, MD - Jefferson University Hospitals

Watch Video

James A Posey MD

Jefferson University Physician

Academic Title

Professor

Specialties

Medical Oncology
Medical Oncology - Colorectal Cancer
Medical Oncology - Esophageal Cancer
Medical Oncology - Gastrointestinal (GI) Cancer
Medical Oncology - Liver Cancer
Medical Oncology - Pancreatic Cancer
Medical Oncology - Stomach Cancer

Book an Appointment

If you have a Jefferson Health MyChart account you can directly schedule within MyChart.

Contact Us

New or returning patients can complete our secure, online appointment request form. A representative from Jefferson will contact you by email to confirm your appointment.

Request an Appointment

If you'd rather speak with a JEFF NOW® representative, click 1-800-JEFFNOW below. You will then be prompted to enter your phone number.

Call 1-800-JEFFNOW

Overview

Locations

Departments & Programs

Education & Fellowships

Howard University College of Medicine, Medical School
Internship: Georgetown University Hospital, DC
Residency: Georgetown University Hospital, DC
Fellowship: Georgetown University Hospital, DC

Board Certification

Medical Oncology
Internal Medicine

Hospital Affiliation

Thomas Jefferson University Hospital
Methodist Hospital Division of Thomas Jefferson University Hospital

Insurances Accepted

Jefferson physicians accept most health insurance plans, including those listed below. However, plan acceptance may vary by practice and may be subject to change. If you have questions about whether a specific physician accepts your insurance, please contact your insurance company.

Aetna
Amer Assoc Retired Persons (AARP)
AmeriHealth
AmeriHealth Comprehensive
AmeriHealth HMO
AmeriHealth Major Medical
AmeriHealth Personal Choice
Amerihealth Caritas
BC BS Special Care
Blue Choice
Blue Cross/Blue Shield
Cigna PPO, POS
Consumer Health Network PPO
Coventry/Health America
Delaware Blue Cross/Blue Shield
Devon
Empire BC/BS
Employers Health Network PPO
Evolutions (Guardian Resources)
Federal BCBS
Galaxy
Horizon Blue Cross/Blue Shield
Horizon HMO
HumanaChoicePPO,Medicare,GoldPlusHMO
Intergroup Preferred
Keystone First VIP Choice
Keystone First/Connect
Medallion of New Jersey
Medicaid of PA
Medicare
Mercy LIFE
MultiPlan Inc.
NJ Blue Shield
Oxford of PA
PPO Next
Personal Choice (GPPPN)
Personal Choice 65
PlanCare America
Postal Workers/Mailhandlers
Preferred Care PPO
Premier Blue
Prime Health Services, Inc.
Qualcare
Tricare
UPMC HMO,PPO ReadingHspEmpONLY
UPMC Medicare HMO
US Family Health Plan
United AARP Medicare Complete
United Healthcare

Patient Ratings

Friendliness/courtesy of the care provider:

Explanations the care provider gave you about your problem or condition:

Concern the care provider showed for your questions or worries:

Care provider's efforts to include you in decisions about your treatment:

Information the care provider gave you about medications (if any):

Instructions the care provider gave you about follow-up care (if any):

Degree to which care provider talked with you using words you could understand:

Amount of time the care provider spent with you:

Your confidence in this care provider:

Likelihood of your recommending this care provider to others:

Overall Rating:

Learn more about Patient Ratings

Awards

Philadelphia Magazine's Top Docs 2018

Publications

Cancer of the Pancreas

A routine laboratory data-based model for predicting recurrence after curative resection of stage II colorectal cancer

Determination of an optimal response cut-off able to predict progression-free survival in patients with well-differentiated advanced pancreatic neuroendocrine tumours treated with sunitinib: An alternative to the current RECIST-defined response

Emergency use of uridine triacetate for the prevention and treatment of life-threatening 5-fluorouracil and capecitabine toxicity

Multiregion whole-exome sequencing of matched primary and metastatic tumors revealed genomic heterogeneity and suggested polyclonal seeding in colorectal cancer metastasis

Pancreatic cancer survivors’ preferences, barriers, and facilitators related to physical activity and diet interventions

RNA sequencing of pancreatic adenocarcinoma tumors yields novel expression patterns associated with long-term survival and reveals a role for ANGPTL4

Patterns of Failure for Lymph Node-Positive Resected Pancreatic Adenocarcinoma After Adjuvant Radiotherapy or Gemcitabine-based Chemotherapy Alone

Esophageal and esophagogastric junction cancers, Version 1.2015

Hepatobiliary cancers, version 2.2014

Quantitative perfusion- and diffusion-weighted magnetic resonance imaging of gastrointestinal cancers treated with multikinase inhibitors: A pilot study

Erratum to: Pancreatic adenocarcinoma: a pilot study of quantitative perfusion and diffusion-weighted breath-hold magnetic resonance imaging (Abdom Imaging (2014) 39, (744–752) 10.1007/s00261-014-0107-z)

Pancreatic adenocarcinoma: A pilot study of quantitative perfusion and diffusion-weighted breath-hold magnetic resonance imaging

The effects of liver impairment on the pharmacokinetics of brivanib, a dual inhibitor of fibroblast growth factor receptor and vascular endothelial growth factor receptor tyrosine kinases

Gastric cancer, version 2.2013

Esophageal and esophagogastric junction cancers

A phase i study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally advanced pancreatic cancer

Resectability of pancreatic adenocarcinoma in patients with locally advanced disease downstaged by preoperative therapy: A challenge for MDCT

Phase I trial of weekly tigatuzumab, an agonistic humanized monoclonal antibody targeting death receptor 5 (DR5)

Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: A phase II trial

Contact Us

New or returning patients can complete our secure, online appointment request form. A representative from Jefferson will contact you by email to confirm your appointment.

Request an Appointment

If you'd rather speak with a JEFF NOW® representative, click 1-800-JEFFNOW below. You will then be prompted to enter your phone number.

Call 1-800-JEFFNOW

Primary Location

925 Chestnut Street
Suite 320A
Philadelphia, PA 19107

Phone: (215) 955-8874
Fax: (215) 955-2340

Get Directions

Other Locations

1100 Walnut Street
5th Floor
Philadelphia, PA 19107
Get Directions